The syndrome of systemic carnitine deficiency: Clinical, morphologic, biochemical, and pathophysiologic features

George Karpati, Stirling Carpenter, Andrew G. Engel, Gordon Watters, Jeffrey Allen, Stanley Rothman, Gerald Klassen, Orval A. Mamer

Research output: Contribution to journalArticle

331 Scopus citations

Abstract

An 11-year-old boy had had recurrent episodes of hepatic and cerebral dysfunction and underdeveloped musculature. Overt weakness developed at age 10. Lipid excess, especially in type I fibers, was found in muscle. Hypertrophied smooth endoplasmic reticulum and excessive microbodies were present in liver. Marked carnitine deficiency was shown in skeletal muscle, plasma, and liver. Ketogenesis was impaired on a high fat diet, but omega oxidation of fatty acids was enhanced. There was excessive glucose uptake and essentially no oxidation of labeled long-chain fatty acids by perfused forearm muscles in vivo. Oral replacement therapy restored plasma carnitine levels to normal, but not liver or muscle carnitine levels, and was accompanied by clinical improvement.

Original languageEnglish (US)
Pages (from-to)16-24
Number of pages9
JournalNeurology
Volume25
Issue number1
DOIs
StatePublished - Jan 1975

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'The syndrome of systemic carnitine deficiency: Clinical, morphologic, biochemical, and pathophysiologic features'. Together they form a unique fingerprint.

  • Cite this

    Karpati, G., Carpenter, S., Engel, A. G., Watters, G., Allen, J., Rothman, S., Klassen, G., & Mamer, O. A. (1975). The syndrome of systemic carnitine deficiency: Clinical, morphologic, biochemical, and pathophysiologic features. Neurology, 25(1), 16-24. https://doi.org/10.1212/wnl.25.1.16